Post-traumatic stress disorder in women: current concepts and treatments

Curr Psychiatry Rep. 2002 Dec;4(6):474-86. doi: 10.1007/s11920-002-0076-8.

Abstract

In the US, 13% of women develop post-traumatic stress disorder (PTSD) during their lifetime. An accurate diagnosis of PTSD requires screening for trauma and symptoms of PTSD. Current research in the neurobiologic and psychologic responses to traumatic stress supports the use of pharmacologic and psychosocial interventions. Selective serotonin reuptake inhibitors are the current first-line pharmacotherapy. Efficacious psychosocial interventions include exposure therapy and cognitive processing therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Brain / physiopathology
  • Catecholamines / physiology
  • Cognitive Behavioral Therapy
  • Female
  • Humans
  • Hypothalamo-Hypophyseal System / physiopathology
  • Pituitary-Adrenal System / physiopathology
  • Psychotropic Drugs / therapeutic use*
  • Stress Disorders, Post-Traumatic / physiopathology
  • Stress Disorders, Post-Traumatic / psychology*
  • Stress Disorders, Post-Traumatic / therapy*

Substances

  • Catecholamines
  • Psychotropic Drugs